| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.034 | 0.4 |